Insights

Loading spinner
Gathering insights about RetiSpec

RetiSpec Tech Stack

Media & News

RetiSpec's Email Address Formats

RetiSpec uses at least 2 format(s):
RetiSpec Email FormatsExamplePercentage
First@retispec.comJohn@retispec.com
74%
First.Last@retispec.comJohn.Doe@retispec.com
26%

Frequently Asked Questions

Where is RetiSpec's headquarters located?

Minus sign iconPlus sign icon
RetiSpec's main headquarters is located at Toronto, ON CA. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is RetiSpec's official website and social media links?

Minus sign iconPlus sign icon
RetiSpec's official website is retispec.ai and has social profiles on LinkedIn.

How much revenue does RetiSpec generate?

Minus sign iconPlus sign icon
As of October 2024, RetiSpec's annual revenue reached $3.8M.

What is RetiSpec's NAICS code?

Minus sign iconPlus sign icon
RetiSpec's NAICS code is 5112 - Software Publishers.

How many employees does RetiSpec have currently?

Minus sign iconPlus sign icon
As of October 2024, RetiSpec has approximately 28 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Technology Officer: A. H.Chief Business Officer: C. B.Chief Operating Officer: R. K.. Explore RetiSpec's employee directory with LeadIQ.

What industry does RetiSpec belong to?

Minus sign iconPlus sign icon
RetiSpec operates in the Software Development industry.

What is RetiSpec's email format?

Minus sign iconPlus sign icon
RetiSpec's email format typically follows the pattern of . Find more RetiSpec email formats with LeadIQ.

When was RetiSpec founded?

Minus sign iconPlus sign icon
RetiSpec was founded in 2016.
RetiSpec

RetiSpec

Software DevelopmentOntario, Canada11-50 Employees

RetiSpec is an AI-based company focused on early detection of neurodegenerative diseases through a simple eye exam. RetiSpec's proprietary AI solution leverages existing retinal imaging cameras to provide a non-invasive, accurate and scalable solution for the early detection of Alzheimer's disease. RetiSpec is involved in multiple Alzheimer's and brain health studies in leading hospitals and research networks throughout North America. 
RetiSpec is currently advancing its regulatory and market entry plans for its first clinically-validated test to predict amyloid burden at the point of care, to aid in the evaluation of individuals for Alzheimer's disease and other causes of cognitive decline. 
RetiSpec was recently selected from more than 75 global applicants to receive the Davos Alzheimer's Collaborative inaugural grant for Health System Preparedness to test its technology in optometry settings.

Section iconCompany Overview

Headquarters
Toronto, ON CA
NAICS Code
5112 - Software Publishers
Founded
2016
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $10M

    RetiSpec's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    RetiSpec's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.